| Literature DB >> 34996387 |
Daisuke Kanda1, Yoshiyuki Ikeda2, Takuro Takumi2, Akihiro Tokushige2, Takeshi Sonoda2, Ryo Arikawa2, Kazuhiro Anzaki2, Ippei Kosedo2, Mitsuru Ohishi2.
Abstract
BACKGROUND: Malnutrition affects the prognosis of cardiovascular disease. Acute myocardial infarction (AMI) has been a major cause of death around the world. Thus, we investigated the impact of malnutrition as defined by Geriatric Nutritional Risk Index (GNRI) on mortality in AMI patients.Entities:
Keywords: Acute myocardial infarction; GNRI; GRACE risk score; Malnutrition
Mesh:
Year: 2022 PMID: 34996387 PMCID: PMC8742435 DOI: 10.1186/s12872-021-02448-x
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Baseline characteristics of study patients according to nutritional status
| Variables | Overall | Malnourished group | Non-malnourished group | P value |
|---|---|---|---|---|
| (n = 268) | (n = 51) | (n = 217) | ||
| Age, years | 68 [59, 76] | 71 [66, 83] | 67 [57, 75] | < 0.001 |
| Sex: male, n (%) | 186 (69) | 29 (59) | 157 (72) | 0.042 |
| BMI, kg/m2 | 24.0 [21.6, 26.4] | 20.7 [18.5, 22.3] | 24.5 [22.5, 26.7] | < 0.001 |
| Risk factors, n (%) | ||||
| Hypertension | 194 (72) | 31 (61) | 163 (75) | 0.055 |
| Diabetes mellitus | 148 (55) | 30 (59) | 118 (54) | 0.64 |
| Dyslipidaemia | 174 (65) | 23 (45) | 151 (69) | 0.002 |
| Current smoker | 60 (22) | 4 (8) | 56 (25) | 0.005 |
| Haemodialysis | 35 (13) | 12 (24) | 23 (11) | 0.020 |
| Medication, n (%) | ||||
| Aspirin | 86 (32) | 15 (29) | 71 (33) | 0.74 |
| Thienopyridines | 52 (19) | 13 (25) | 39 (18) | 0.24 |
| Dual antiplatelet therapy | 32 (12) | 6 (12) | 26 (12) | 1.00 |
| Oral anticoagulation | 16 (6) | 8 (16) | 8 (4) | 0.004 |
| Calcium-channel blocker | 92 (34) | 16 (31) | 76 (35) | 0.73 |
| ACEI | 13 (5) | 4 (8) | 9 (4) | 0.28 |
| ARB | 73 (27) | 11 (22) | 62 (29) | 0.38 |
| β-blocker | 40 (15) | 7 (14) | 33 (15) | 1.00 |
| Statin | 99 (37) | 16 (31) | 83 (38) | 0.42 |
| Laboratory data | ||||
| LDL-C, mg/dL | 96 [73, 123] | 78 [61, 108] | 100 [77, 130] | < 0.001 |
| HDL-C, mg/dL | 46 [40,58] | 46 [37, 62] | 47 [40, 57] | 0.78 |
| Triglyceride, mg/dL | 99 [73, 146] | 72 [49, 93] | 109 [80, 158] | < 0.001 |
| Albumin, g/dL | 3.8 [3.5, 4.2] | 3.0 [2.6, 3.3] | 4.0 [3.7, 4.3] | < 0.001 |
| Uric acid, mg/dL | 5.6 [4.3, 6.8] | 6.2 [5.0, 8.1] | 5.5 [4.3, 6.7] | 0.022 |
| FPG, mg/dL | 129 [107,177] | 141 [104, 219] | 127 [107, 171] | 0.157 |
| Haemoglobin A1c, % | 6.3 [5.6, 7.2] | 6.5 [5.6, 7.7] | 6.3 [5.6, 7.2] | 0.60 |
| Creatinine, mg/dL | 0.95 [0.75,1.32] | 1.36 [0.88, 3.12] | 0.91 [0.74,1.19] | < 0.001 |
| eGFR, mL/min/1.73 m2 | 54.7 [37.8, 72.2] | 40.6 [13.8, 54.5] | 57.1 [41.6, 74.8] | < 0.001 |
| LVEF, % | 39.6 [39.6, 52.2] | 40.7 [31.4, 51.4] | 55.0 [40.0, 62.0] | < 0.001 |
| Condition, n (%) | ||||
| STEMI | 140 (52) | 27 (53) | 113 (52) | 1.00 |
| Non-STEMI | 128 (48) | 24 (47) | 104 (48) | 1.00 |
| GRACE risk score | 130.0 [107.3, 157.0] | 166 [132, 188] | 124 [104, 148] | < 0.001 |
| GNRI | 102.4 [94.6, 109.5] | 86.4 [77.2, 89.6] | 105.1 [99.5, 111.9] | < 0.001 |
Values are shown as median with interquartile range
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BMI, body mass index; eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; GNRI, Geriatric Nutritional Risk Index; GRACE, Global Registry of Acute Coronary Events; HDL-C, high-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; LDL-C, low-density lipoprotein cholesterol; STEMI, ST-elevation myocardial infarction
Cumulative deaths after PCI based on nutritional status
| Overall | Malnourished group | Non-malnourished group | P value | |
|---|---|---|---|---|
| (n = 268) | (n = 51) | (n = 217) | ||
| Within 1 month after PCI | ||||
| All-cause death | 17 (6%) | 12 (24%) | 5 (2%) | < 0.001 |
| Cardiac death | 15 (6%) | 11 (22%) | 4 (2%) | < 0.001 |
| Non-cardiac death | 2 (1%) | 1 (4%) | 1 (1%) | 0.32 |
| Beyond 1 month after PCI | ||||
| All-cause death | 16 (6%) | 8 (16%) | 8 (4%) | 0.017 |
| Cardiac death | 9 (3%) | 6 (12%) | 3 (1%) | 0.002 |
| Non-cardiac death | 7 (3%) | 2 (4%) | 5 (2%) | 0.62 |
| Full follow-up period after PCI | ||||
| All-cause death | 33 (12%) | 20 (39%) | 13 (6%) | < 0.001 |
| Cardiac death | 24 (9%) | 17 (33%) | 7 (3%) | < 0.001 |
| Non-cardiac death | 9 (3%) | 3 (6%) | 6 (3%) | 0.38 |
PCI, percutaneous coronary intervention
Fig. 1Kaplan–Meier survival curves for all-cause death after percutaneous coronary intervention
Univariate Cox proportional hazards regression analysis for all-cause death
| Within 1 month after PCI | Beyond 1 month after PCI | Full follow-up period after PCI | ||||
|---|---|---|---|---|---|---|
| HR | P value | HR | P value | HR | P value | |
| Age | 1.04 (0.98–1.11) | 0.20 | 1.03 (0.99–1.08) | 0.170 | 1.04 (0.99–1.08) | 0.08 |
| Sex: male | 2.08 (0.60–7.25) | 0.21 | 0.75 (0.27–2.07) | 0.58 | 1.19 (0.56–2.57) | 0.64 |
| BMI | 0.83 (0.68–0.99) | 0.048 | 0.88 (0.75–1.01) | 0.068 | 0.85 (0.74–0.96) | 0.011 |
| Hypertension | 1.77 (0.47–6.58) | 0.40 | 1.68 (0.61–4.64) | 0.32 | 1.63 (0.65–4.06) | 0.29 |
| Diabetes mellitus | 1.56 (0.42–5.82) | 0.51 | 1.26 (0.47–3.37) | 0.63 | 1.73 (0.69–4.33) | 0.24 |
| Dyslipidaemia | 0.62 (0.16–2.31) | 0.48 | 0.85 (0.31–2.33) | 0.75 | 0.68 (0.27–1.69) | 0.41 |
| Current smoker | 1.67 (0.72–4.88) | 0.57 | 1.10 (0.36–3.44) | 0.86 | 1.46 (0.42–5.02) | 0.55 |
| Haemodialysis | 1.32 (0.17–10.56) | 0.79 | 1.63 (0.17–10.56) | 0.79 | 3.01 (0.40–22.51) | 0.28 |
| Aspirin | 0.50 (0.11–2.45) | 0.40 | 0.88 (0.31–2.54) | 0.82 | 0.80 (0.31–2.12) | 0.66 |
| Thienopyridines | 0.89 (0.26–3.11) | 0.85 | 0.25 (0.03–1.92) | 0.104 | 0.55 (0.19–1.56) | 0.23 |
| Dual antiplatelet therapy | 0.92 (0.11–7.32) | 0.93 | 0.44 (0.05–3.35) | 0.37 | 0.83 (0.19–3.60) | 0.81 |
| Oral anticoagulation | 1.47 (0.18–11.75) | 0.72 | 2.04 (0.46–8.98) | 0.40 | 2.18 (0.63–7.49) | 0.22 |
| Calcium-channel blocker | 0.96 (0.24–3.86) | 0.96 | 0.80 (0.27–2.28) | 0.66 | 0.88 (0.33–2.31) | 0.79 |
| ACEI | 1.52 (0.33–6.28) | 0.56 | 2.43 (0.55–10.71) | 0.294 | 1.56 (0.36–6.76) | 0.55 |
| ARB | 0.33 (0.04–2.66) | 0.29 | 0.89 (0.31–2.58) | 0.84 | 0.47 (0.14–1.63) | 0.24 |
| β-blocker | 0.49 (0.10–2.37) | 0.38 | 0.39 (0.05–2.97) | 0.30 | 0.82 (0.19–3.57) | 0.80 |
| Statin | 0.46 (0.10–2.28) | 0.35 | 0.91 (0.33–2.52) | 0.87 | 0.75 (0.28–1.96) | 0.56 |
| LDL-C | 0.98 (0.96–1.04) | 0.12 | 0.99 (0.97–1.01) | 0.28 | 0.98 (0.96–0.99) | 0.062 |
| HDL-C | 0.98 (0.92–1.03) | 0.43 | 0.98 (0.93–1.03) | 0.46 | 0.98 (0.94–1.03) | 0.52 |
| Triglyceride | 0.98 (0.96–1.00) | 0.060 | 0.99 (0.98–1.00) | 0.44 | 0.99 (0.98–1.01) | 0.054 |
| Albumin | 0.22 (0.09–0.53) | < 0.001 | 0.32 (0.16–0.67) | 0.003 | 0.21 (0.11–0.38) | < 0.001 |
| FPG | 0.98 (0.97–1.00) | 0.20 | 1.00 (0.99–1.01) | 0.45 | 1.00 (0.99–1.00) | 0.99 |
| eGFR | 0.99 (0.96–1.01) | 0.25 | 0.99 (0.97–1.01) | 0.30 | 0.98 (0.97–1.00) | 0.085 |
| LVEF | 0.94 (0.90–0.99) | 0.025 | 0.97 (0.94–1.01) | 0.112 | 0.93 (0.91–0.97) | < 0.001 |
| GRACE risk score | 1.03 (1.01–1.04) | < 0.001 | 1.02 (1.01–1.03) | < 0.001 | 1.03 (1.02–1.04) | < 0.001 |
Malnutrition (GNRI < 92.0) | 10.30 (2.57–41.21) | 0.001 | 4.59 (1.71–12.32) | 0.003 | 9.73 (3.83–24.75) | < 0.001 |
CI, confidence interval; HR, hazard ratio. Other abbreviations are as in Tables 1 and 2
Predictive values of malnutrition for all-cause death as determined by multivariate Cox proportional hazards regression analysis modelling
| Model 1 | Model 2 | Model 3 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| HR | 95%CI | P value | HR | 95%CI | P value | HR | 95%CI | P value | |
| Within 1 month after PCI | |||||||||
| Age | 0.98 | 0.94–1.03 | 0.42 | 1.02 | 0.95–1.10 | 0.95 | 0.96 | 0.92–1.01 | 0.07 |
| LVEF | – | – | – | 0.93 | 0.89–0.97 | < 0.001 | – | – | – |
| GRACE risk score | – | – | – | – | – | – | 1.03 | 1.01–1.04 | < 0.001 |
| Malnutrition | 13.08 | 4.41–38.81 | < 0.001 | 6.74 | 2.13–21.33 | 0.001 | 7.04 | 2.30–21.51 | < 0.001 |
| Beyond 1 month after PCI | |||||||||
| Age | 1.01 | 0.97–1.06 | 0.55 | 1.02 | 0.97–1.07 | 0.44 | 0.99 | 0.94–1.04 | 0.70 |
| LVEF | – | – | – | 0.98 | 0.94–1.01 | 0.216 | – | – | – |
| GRACE risk score | – | – | – | – | – | – | 1.02 | 1.01–1.03 | 0.002 |
| Malnutrition | 4.11 | 1.44–11.74 | 0.008 | 3.47 | 1.15–10.39 | 0.032 | 3.10 | 1.70–8.96 | 0.037 |
| Full follow-up period after PCI | |||||||||
| Age | 0.99 | 0.97–1.03 | 0.85 | 1.01 | 0.97–1.04 | 0.71 | 0.98 | 0.94–1.03 | 0.51 |
| LVEF | – | – | – | 0.95 | 0.93–0.98 | < 0.001 | – | – | – |
| GRACE risk score | – | – | – | – | – | – | 1.02 | 1.01–1.03 | 0.002 |
| Malnutrition | 7.38 | 3.55–15.32 | < 0.001 | 5.82 | 2.05–16.50 | < 0.001 | 5.64 | 1.97–16.13 | 0.001 |
Model 1, adjusted for age; Model 2, adjusted for variables in Model 1 plus LVEF; Model 3, adjusted for variables in Model 1 plus GRACE risk score. CI, confidence interval; HR, hazard ratio. Other abbreviations are as in Tables 1 and 2
Fig. 2Receiver-operating characteristic curves for predicting all-cause death. A within 1 month after PCI, B beyond 1 month after PCI, C during the full follow-up period after PCI. AUC, area under the curve; GNRI, Geriatric Nutritional Risk Index; GRACE, Global Registry of Acute Coronary Events; PCI, percutaneous coronary intervention
Fig. 3Calibration plots comparing predicted and actual mortality of GNRI and GRACE score models. A, D within 1 month after PCI, B, E beyond 1 month after PCI, C, F during the full follow-up period after PCI. GNRI, Geriatric Nutritional Risk Index; GRACE, Global Registry of Acute Coronary Events; PCI, percutaneous coronary intervention